The Influence of Side Effect Information Framing on Nocebo Effects

Abstract Background One contributing factor to the development of nocebo effects is information provided about possible side effects. However, nondisclosure of information can be problematic. Purpose We assessed whether positively framed side effect information (highlighting likelihood of not experi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of behavioral medicine 2019-06, Vol.53 (7), p.621-629
Hauptverfasser: Faasse, Kate, Huynh, Anna, Pearson, Sarah, Geers, Andrew L, Helfer, Suzanne G, Colagiuri, Ben
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background One contributing factor to the development of nocebo effects is information provided about possible side effects. However, nondisclosure of information can be problematic. Purpose We assessed whether positively framed side effect information (highlighting likelihood of not experiencing side effects) can reduce nocebo effects compared to negatively framed information (highlighting likelihood of experiencing side effects). Methods One hundred twelve participants took part in research ostensibly assessing the influence of benzodiazepines (actually sham capsules) on anxiety. Participants were randomized to receive a sham capsule with positively or negatively framed information about four side effects, or a no-treatment control condition. Side effect expectations were assessed after information provision. Framed side effects and other unmentioned symptoms were assessed during the session and 24-hr follow-up. Results Nocebo effects occurred in symptoms presented as side effects (regardless of framing) during the study session and follow-up (ps < .003). At follow-up, there was also a nocebo effect in other unmentioned symptoms (p = .018). Positive framing reduced side effect symptoms compared with negative framing during the study session (p = .037), but this effect was no longer present at follow-up (p = .53). Side effect expectations did not differ between the framing conditions (p = .14). Conclusions Positive framing reduced side effects short-term, but not at follow-up. Expectations did not differ between negative and positive framing. Nocebo effects appeared to generalize to other unmentioned symptoms over a 24-hr period. Further research is needed to determine whether the initial impact of positive framing can be maintained over time. Presenting medication side effect information in a more positive light - by focusing on the likelihood of not experiencing side effects - can reduce the nocebo effect.
ISSN:0883-6612
1532-4796
DOI:10.1093/abm/kay071